◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Uno Minda Limited (UNOMINDA) Revenue 2022–TTM

Name: Uno Minda Limited (UNOMINDA) revenue history 2022-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-11-01

Uno Minda Limited annual revenue for fiscal TTM was ₹207.3 billion, an increase of 6.9% from ₹193.9 billion in fiscal 2026. All figures are reported results from public filings — no estimates or projections.

UNOMINDA Annual Revenue

Revenue (annual)	TTM → 2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹207.3B	₹193.9B	₹165.8B	₹139.1B	₹110.8B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

UNOMINDA Quarterly Revenue

Revenue (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹55.6B	₹53.4B	₹50.2B	₹48.1B	₹44.9B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

5334 Revenue — Niterra Co., Ltd.
5101 Revenue — The Yokohama Rubber Company, Limited
5991 Revenue — NHK Spring Co., Ltd.
6473 Revenue — JTEKT Corporation
5105 Revenue — Toyo Tire Corporation
7276 Revenue — Koito Manufacturing Co., Ltd.

More UNOMINDA metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow

All UNOMINDA financial statements → Interactive UNOMINDA charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.